《Cancer Cell International》雜志的最新年發文量為314篇。
這表明該刊在每年都會精選并發表一定數量的高質量文章，以保持其在腫瘤學領域的學術影響力。
該刊聚焦于醫學-腫瘤學領域的前沿研究，致力于推動該領域新技術和新知識的傳播與應用。同時它積極鼓勵研究人員詳細發表其高質量的實驗研究和理論成果。
該刊的平均審稿周期約為 約1月 。
Cancer Cell International 雜志發文統計
文章名稱引用次數
- Resistance a major hindrance to chemotherapy in hepatocellular carcinoma: an insight37
- hsa_circ_0081143 promotes cisplatin resistance in gastric cancer by targeting miR-646/CDK6 pathway34
- Circular RNA CDR1as sponges miR-7-5p to enhance E2F3 stability and promote the growth of nasopharyngeal carcinoma25
- Up-regulated lncRNA XIST contributes to progression of cervical cancer via regulating miR-140-5p and ORC125
- The effect of 2D and 3D cell cultures on treatment response, EMT profile and stem cell features in head and neck cancer22
- Tumor mutation burden: from comprehensive mutational screening to the clinic22
- The m(6)A eraser FTO facilitates proliferation and migration of human cervical cancer cells21
- Long non-coding RNA CASC2 upregulates PTEN to suppress pancreatic carcinoma cell metastasis by downregulating miR-2120
- Identification of a six-gene signature predicting overall survival for hepatocellular carcinoma20
- Identification of circRNA-miRNA-mRNA regulatory network in gastric cancer by analysis of microarray data19
國家/地區發文量
- CHINA MAINLAND1005
- USA76
- Iran34
- Italy16
- GERMANY (FED REP GER)12
- South Korea12
- Canada10
- Taiwan10
- India9
- Japan9
